Hysteroscopy Procedures Market Outlook (2022 to 2032)
Newly-released Hysteroscopy Procedures analysis report by Future Market Insights shows that global sales of the Hysteroscopy Procedures Market in 2021 were held at US$ 3.7 billion. With 8.4%, the projected market growth from 2022 to 2032 is expected to be slightly higher than the historical growth. Hospitals are expected to be the highest revenue-generating end user, projected to grow at a CAGR of over 9.3% from 2022 to 2032.
Attributes
Details
Hysteroscopy Procedures Market CAGR (2022 to 2032)
8.4%
Hysteroscopy Procedures Market Size (2022)
US$ 4 billion
Hysteroscopy Procedures Market Size (2032)
US$ 9 billion
The USA Market CAGR (2022 to 2032)
8.9%
Key Companies Covered
Medtronic
Stryker Corporation
Hologic Inc.
KARL STORZ SE & Co. KG
Medical devises Business Services Inc.
Olympus Corporation
Delmont Imaging
CooperCompanies
Richard Wolf GmbH
B. Braun Melsungen AG
Maxer Endoscopy GmbH
Boston Scientific Corp.
MedGyn Products, Inc.
Meditrina, Inc. (Aveta)
Lina Medical APS
Luminelle
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Revenue of Hysteroscopy Procedures Market from 2017 to 2021 Compared to Demand Outlook for 2022 to 2032
As per the Global Hysteroscopy Procedures Market research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Hysteroscopy Procedures Market increased at around 7.7% CAGR.
The key revenue drivers which affected the market are the increasing incidence of gynecological diseases like ovarian cancer, uterine fibroids, and ovarian cysts, and the growing trend for minimally invasive surgery worldwide. Ovarian cysts are very commonly encountered in females, wherein 7% of women worldwide are reported to have ovarian cysts. In the United States, there are 15 cases per 100 thousand women annually. Women ovarian cysts are encountered in all premenopausal women and they are also found in 18% of postmenopausal women. Due to the rise in the number of gynecological diseases, the use of Hysteroscopy Procedures is increased in Hospitals, clinics, and ambulatory surgical centers.
Which Factors are Propelling Hysteroscopy Procedures Demand?
With the increasing prevalence of gynecological diseases like uterine fibroids, menstrual disorders, ovarian cysts, and ovarian cancer, there was an increase in hysteroscopy procedures. Health uterine fibroids affect 20-25% of reproductive-age women by the age of 50 and the prevalence of uterine fibroid disease varies by age group, ranging from 5.4% to 23.6%. As a result, there is an increase in demand for hysteroscopy procedures as these procedures are used in the diagnosis of gynecological diseases.
Another factor increasing the demand for hysteroscopy procedures is the growing trend for minimally invasive surgery. Minimally invasive surgery has been the standard procedure for treating gynecological diseases over the last two decades. The advantage of minimally invasive surgery in gynecological diseases are less pain, reduced hospital stays, less loss of blood, and reduced risk of scaring. Diagnostic procedures like hysteroscopy are used to identify anomalies like excruciating stomach cramps, heavy bleeding, repeated miscarriages, or trouble conceiving.
Due to an increase in the use of minimally invasive surgery demand for hysteroscopy procedures is on the rise. The rising cases of uterine cancer have also increased the number of hysteroscopy procedures. According to the report of the American Cancer Society, more than 65 thousand cases are anticipated to be diagnosed in 2022. Therefore, these factors are driving the growth of the market.
The rising prevalence of polycystic ovarian syndrome. It is a syndrome in which the ovaries create an abnormally large amount of androgens, male sex hormones that are normally present in lower amounts in women. According to the National Library of Medicine, polycystic ovarian syndrome (PCOS) affects 4% to 20% of women who are of reproductive age worldwide. As a result, there is a rise in cases of polycystic ovarian syndrome cases globally and in the diagnosis of polycystic ovarian syndrome there is the use of hysteroscopy procedures. Which is increasing demand for hysteroscopy procedures worldwide.
According to the report of the World Ovarian Cancer Coalition more than 300 thousand cases of ovarian cancer were diagnosed and from which 200 thousand women died due to ovarian cancer. The number is anticipated to rise at a rate of 37% by 2040. In the United States, there are 15 cases of ovarian cancer per 100 thousand women annually. Due to rising cases of ovarian cancer, there is a rise in the number of hysteroscopy procedures performed around the world.
Find your sweet spots for generating winning opportunities in this market.
What factors restrain the Growth of the Hysteroscopy Procedures Market?
The use of diagnostic methods such as complete blood count, drug therapies, and ultrasound, is limiting the number of hysteroscopy procedures. Physicians and doctors prescribe drug therapies as the first line of treatment for gynecological diseases. The hysteroscopy procedure is only recommended by physicians only when other diagnostic procedures fail to properly diagnose a specific condition.
In hysteroscopy procedures, a few adverse effects can occur like vaginal bleeding, cramping, and severe abdominal pain, which reduces the demand for hysteroscopy procedures this adverse effect of hysteroscopy act as a restraint for market growth. Another factor restraining the growth of the market is the high cost of hysteroscopy procedures. In the United States average cost of a hysteroscopy procedure ranges from US$ 750 to US$ 3,500. All these factors are impacting the demand for hysteroscopy procedures and acting as a restraint for the hysteroscopy procedures market.
Region-wise Insights
Which Region is projected to offer the Largest Hysteroscopy Procedures Market Opportunity?
During the projection period, the North American Hysteroscopy Procedures Market is predicted to be the leading market for Hysteroscopy Procedures. The value of Hysteroscopy Proceduresin North America increased at a CAGR of around 8% from 2017 to 2021.
In the United States from the 8th to the 14th of May is observed as National Women's Health Week. Which motivates women to prioritize their health and take care of themselves. This is rising awareness about women’s health in North America and thus increasing demand for hysteroscopy procedures.
Uterine cancer accounts for 3.4% of all new cancer cases in the United States, according to National Cancer Institute research. Hence, due to the prevalence of cases of uterine cancer in the region, the demand for diagnostics. Consequently, the cost of research and development is very high in the United States. These factors are likely to increase the demand for hysteroscopy procedures in the region.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Country-wise Analysis
The USA Hysteroscopy Procedures Market
The United States is expected to account for the highest market of US$ 3.1 billion by the end of 2032. Also, the market in the country is projected to account for an absolute dollar growth of US$ 1.8 billion. This is attributable to a number of variables, including growth in the prevalence of gynecological illnesses, increased understanding of various medical alternatives, developed healthcare facilities, and the existence of skilled physicians. Government policies and regulations are favoring the market. The healthcare system in the United States includes both commercial and governmental health insurance. Medicare and Medicaid are the two largest The USA government-funded programs.
According to the report of the Congressional Research Service the United States government spends more than US$ 3.9 Tn on various types of health consumption expenditures which are increasing the number of hysteroscopy procedures in the country. The increase in the cases of endometriosis is directly increasing the number of hysteroscopy procedures in the United States. Endometriosis currently affects more than 5.5 million women in the United States and the number is expected to rise in the future.
The existence and development of new healthcare facilities in the United States are helping boost the growth of the hysteroscopy procedures market. As per the report of the USA Bureau of Labor Statistics, there are more than 13 thousand hospitals in the United States. The skilled employees in the hospital also play important role in carrying out hysteroscopy procedures. In 2019, there were around 22 million hospital employees in the United States, according to the United States Census Bureau. Hence, due to the presence of a developed healthcare system and skilled hospital employees in the United States. The demand for hysteroscopy procedures is increasing. As a result, these factors are driving the hysteroscopy procedures market in the United States.
The United Kingdom Hysteroscopy Procedures Market
The market for hysteroscopy procedures in the United Kingdom is projected to reach a valuation of US$ 349 million by 2032. The market in the country is projected to garner an absolute dollar opportunity of US$ 181 million from 2022 to 2032, at a CAGR of 7.6%.
Japan Hysteroscopy Procedures Market
The market for hysteroscopy procedures in Japan is projected to reach a valuation of US$ 336 million by 2032. The market in the country is projected to garner an absolute dollar opportunity of US$ 195 million from 2022 to 2032, at a CAGR of 9.1%.
South Korea Hysteroscopy Procedures Market
The market for hysteroscopy procedures in Japan is projected to reach a valuation of US$ 185.2 million by 2032. The market in the country is projected to garner an absolute dollar opportunity of US$ 102 million from 2022 to 2032, at a CAGR of 8.3%.
Category-wise Insights
Why Hysteroscopy Procedures Market through Hospitals is projected to Witness the Fastest Growth?
Market revenue throughhospitals is forecasted to grow at a CAGR of over 9.3% from 2022 to 32. Due to a higher volume of patients for gynecological procedures than other healthcare facilities, the market value through hospitalsincreased at a CAGR of around 8.2% from 2017 to 2021. According to the report of the National Library of Medicine, more than 30 thousand myomectomies surgeries for fibroids are performed in the United States annually. Furthermore, because hospitals provide primary healthcare facilities in the majority of nations, the number of hysteroscopy operations performed in hospitals is higher than in other healthcare facilities.
Competitive Analysis
The companies in the Hysteroscopy Procedures market are focused on their alliances, and collaborations. The key companies in the hysteroscopy procedures market include Medtronic, Stryker Corporation, Hologic Inc., KARL STORZ SE & Co. KG, Medical Devices Business Services Inc., Olympus Corporation, Delmont Imaging, CooperCompanies, Richard Wolf GmbH, B. Braun Melsungen AG, Maxer Endoscopy GmbH, Boston Scientific Corp., MedGyn Products, Inc., Meditrina, Inc., Lina Medical APS, and Luminelle.
Some of the recent developments of key Hysteroscopy Procedures market providers are as follows:
In May 2020, Olympus Corporation signed an agreement with UVision 360 to market its LUMINELLE DTx hysteroscopy equipment in the United States with an objective to strengthen and continue growth in the United States' hysteroscopy procedure market.
In November 2019, the AvetaTM Hysteroscopy System has been introduced by Meditrina, Inc. during the American Association of Gynecologic Laparoscopists convention. The launch of the new product will help Meditirna, Inc to strengthen its position in the market and expand its hysteroscopy procedure product portfolio.
In January 2019, Hologic Inc. launched the Omni hysteroscope in the United States, a three-in-one modular scope with superior imaging capabilities suited for both diagnostic and therapeutic hysteroscopic end uses.
Similarly, recent developments related to companies in Hysteroscopy Procedures Market have been tracked by the team at Future Market Insights, which are available in the full report.
Hysteroscopy Procedures Market Segmentation
By End Use:
Hospitals
Clinics
Ambulatory Surgery Centers (ASCs)
By Region:
North America
Latin America
Europe
APAC
Middle East and Africa (MEA)
Frequently Asked Questions
How much is the current worth of the Hysteroscopy Procedures Market?
The global Hysteroscopy Procedures Market is worth more than US$ 4 billion at present.
What is the sales forecast for Hysteroscopy Procedures Market?
The value of the Hysteroscopy Procedures Market is projected to increase at a CAGR of around 8.4% from 2022 to 2032.
What was the last 5 year’s market CAGR?
The value of the Hysteroscopy Procedures Market increased at a CAGR of around 7.7% from 2017 to 2021.
What are the key Hysteroscopy Procedures Market Trends?
The demand for Hysteroscopy Procedures has increased tremendously. The global demand for Hysteroscopy Procedures is being fueled by a considerable increase in gynecological diseases and uterine cancer.
At what percentage is sales of Hysteroscopy Procedures Market going to register growth in the USA?
The growth of the market for Hysteroscopy Procedures in the USA is projected to expand at a CAGR of around 8.9% from 2022 to 2032.
At what percentage is sales of Hysteroscopy Procedures Market going to register growth in China?
The growth of the market for Hysteroscopy Procedures in China is projected to expand at a CAGR of around 10.0% from 2022 to 2032.
What do statistics for South Korea and Japan reveal?
While the market in South Korea is expected to grow at nearly 8.3%, the market in Japan is projected to register a CAGR of nearly 9.1% during 2022 to 2032.
Table of Content
1. Executive Summary | Hysteroscopy Procedures Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Investment Feasibility Matrix
3.6. PESTLE and Porter’s Analysis
3.7. Regulatory Landscape
3.7.1. By Key Regions
3.7.2. By Key Countries
3.8. Regional Parent Market Outlook
4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032
4.1. Historical Market Size Value (US$ million) Analysis, 2017 to 2021
4.2. Current and Future Market Size Value (US$ million) Projections, 2022 to 2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End-use
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ million) Analysis By End-use, 2017 to 2021
5.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By End-use, 2022 to 2032
5.3.1. Hospitals
5.3.2. Clinics
5.3.3. Ambulatory Surgery Centers (ASCs)
5.4. Y-o-Y Growth Trend Analysis By End-use, 2017 to 2021
5.5. Absolute $ Opportunity Analysis By End-use, 2022 to 2032
6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
6.1. Introduction
6.2. Historical Market Size Value (US$ million) Analysis By Region, 2017 to 2021
6.3. Current Market Size Value (US$ million) Analysis and Forecast By Region, 2022 to 2032
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa
6.4. Market Attractiveness Analysis By Region
7. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
7.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021
7.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032
7.2.1. By Country
7.2.1.1. The USA
7.2.1.2. Canada
7.2.2. By End-use
7.3. Market Attractiveness Analysis
7.3.1. By Country
7.3.2. By End-use
7.4. Key Takeaways
8. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
8.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021
8.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032
8.2.1. By Country
8.2.1.1. Brazil
8.2.1.2. Mexico
8.2.1.3. Rest of Latin America
8.2.2. By End-use
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By End-use
8.4. Key Takeaways
9. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
9.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021
9.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032
9.2.1. By Country
9.2.1.1. Germany
9.2.1.2. The United Kingdom.
9.2.1.3. France
9.2.1.4. Spain
9.2.1.5. Italy
9.2.1.6. Russia
9.2.1.7. Rest of Europe
9.2.2. By End-use
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By End-use
9.4. Key Takeaways
10. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
10.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021
10.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032
10.2.1. By Country
10.2.1.1. China
10.2.1.2. Japan
10.2.1.3. India
10.2.1.4. South Korea
10.2.1.5. Australia
10.2.1.6. Rest of APAC
10.2.2. By End-use
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By End-use
10.4. Key Takeaways
11. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
11.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021
11.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032
11.2.1. By Country
11.2.1.1. South Africa
11.2.1.2. Saudi Arabia
11.2.1.3. UAE
11.2.1.4. Israel
11.2.1.5. Rest of Middle East and Africa (MEA)
11.2.2. By End-use
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By End-use
11.4. Key Takeaways
12. Key Countries Market Analysis
12.1. The USA
12.1.1. Pricing Analysis
12.1.2. Market Share Analysis, 2021
12.1.2.1. By End-use
12.2. Canada
12.2.1. Pricing Analysis
12.2.2. Market Share Analysis, 2021
12.2.2.1. By End-use
12.3. Brazil
12.3.1. Pricing Analysis
12.3.2. Market Share Analysis, 2021
12.3.2.1. By End-use
12.4. Mexico
12.4.1. Pricing Analysis
12.4.2. Market Share Analysis, 2021
12.4.2.1. By End-use
12.5. Germany
12.5.1. Pricing Analysis
12.5.2. Market Share Analysis, 2021
12.5.2.1. By End-use
12.6. The United Kingdom.
12.6.1. Pricing Analysis
12.6.2. Market Share Analysis, 2021
12.6.2.1. By End-use
12.7. France
12.7.1. Pricing Analysis
12.7.2. Market Share Analysis, 2021
12.7.2.1. By End-use
12.8. Spain
12.8.1. Pricing Analysis
12.8.2. Market Share Analysis, 2021
12.8.2.1. By End-use
12.9. Italy
12.9.1. Pricing Analysis
12.9.2. Market Share Analysis, 2021
12.9.2.1. By End-use
12.10. Russia
12.10.1. Pricing Analysis
12.10.2. Market Share Analysis, 2021
12.10.2.1. By End-use
12.11. China
12.11.1. Pricing Analysis
12.11.2. Market Share Analysis, 2021
12.11.2.1. By End-use
12.12. Japan
12.12.1. Pricing Analysis
12.12.2. Market Share Analysis, 2021
12.12.2.1. By End-use
12.13. India
12.13.1. Pricing Analysis
12.13.2. Market Share Analysis, 2021
12.13.2.1. By End-use
12.14. South Korea
12.14.1. Pricing Analysis
12.14.2. Market Share Analysis, 2021
12.14.2.1. By End-use
12.15. Australia
12.15.1. Pricing Analysis
12.15.2. Market Share Analysis, 2021
12.15.2.1. By End-use
12.16. South Africa
12.16.1. Pricing Analysis
12.16.2. Market Share Analysis, 2021
12.16.2.1. By End-use
12.17. Saudi Arabia
12.17.1. Pricing Analysis
12.17.2. Market Share Analysis, 2021
12.17.2.1. By End-use
12.18. UAE
12.18.1. Pricing Analysis
12.18.2. Market Share Analysis, 2021
12.18.2.1. By End-use
12.19. Israel
12.19.1. Pricing Analysis
12.19.2. Market Share Analysis, 2021
12.19.2.1. By End-use
13. Market Structure Analysis
13.1. Competition Dashboard
13.2. Competition Benchmarking
13.3. Market Share Analysis of Top Players
13.3.1. By Regional
13.3.2. By End-use
14. Competition Analysis
14.1. Competition Deep Dive
14.1.1. Medtronic
14.1.1.1. Overview
14.1.1.2. Product Portfolio
14.1.1.3. Profitability by Market Segments
14.1.1.4. Sales Footprint
14.1.1.5. Strategy Overview
14.1.1.5.1. Marketing Strategy
14.1.2. Stryker Corp
14.1.2.1. Overview
14.1.2.2. Product Portfolio
14.1.2.3. Profitability by Market Segments
14.1.2.4. Sales Footprint
14.1.2.5. Strategy Overview
14.1.2.5.1. Marketing Strategy
14.1.3. Hologic, Inc.
14.1.3.1. Overview
14.1.3.2. Product Portfolio
14.1.3.3. Profitability by Market Segments
14.1.3.4. Sales Footprint
14.1.3.5. Strategy Overview
14.1.3.5.1. Marketing Strategy
14.1.4. KARL STORZ SE & Co. KG
14.1.4.1. Overview
14.1.4.2. Product Portfolio
14.1.4.3. Profitability by Market Segments
14.1.4.4. Sales Footprint
14.1.4.5. Strategy Overview
14.1.4.5.1. Marketing Strategy
14.1.5. Medical Devices Business Services, Inc.
14.1.5.1. Overview
14.1.5.2. Product Portfolio
14.1.5.3. Profitability by Market Segments
14.1.5.4. Sales Footprint
14.1.5.5. Strategy Overview
14.1.5.5.1. Marketing Strategy
14.1.6. Olympus Corp
14.1.6.1. Overview
14.1.6.2. Product Portfolio
14.1.6.3. Profitability by Market Segments
14.1.6.4. Sales Footprint
14.1.6.5. Strategy Overview
14.1.6.5.1. Marketing Strategy
14.1.7. Delmont Imaging
14.1.7.1. Overview
14.1.7.2. Product Portfolio
14.1.7.3. Profitability by Market Segments
14.1.7.4. Sales Footprint
14.1.7.5. Strategy Overview
14.1.7.5.1. Marketing Strategy
14.1.8. B. Braun Melsungen AG
14.1.8.1. Overview
14.1.8.2. Product Portfolio
14.1.8.3. Profitability by Market Segments
14.1.8.4. Sales Footprint
14.1.8.5. Strategy Overview
14.1.8.5.1. Marketing Strategy
14.1.9. Richard Wolf GmbH
14.1.9.1. Overview
14.1.9.2. Product Portfolio
14.1.9.3. Profitability by Market Segments
14.1.9.4. Sales Footprint
14.1.9.5. Strategy Overview
14.1.9.5.1. Marketing Strategy
14.1.10. CooperCompanies
14.1.10.1. Overview
14.1.10.2. Product Portfolio
14.1.10.3. Profitability by Market Segments
14.1.10.4. Sales Footprint
14.1.10.5. Strategy Overview
14.1.10.5.1. Marketing Strategy
15. Assumptions & Acronyms Used16. Research Methodology
